tiprankstipranks
Profound Medical (PROF)
NASDAQ:PROF
US Market

Profound Medical (PROF) Income Statement

80 Followers

Profound Medical Income Statement

Last quarter (Q2 2026), Profound Medical's total revenue was C$2.42M, an increase of 9.40% from the same quarter last year. In Q2, Profound Medical's net income was C$-9.29M. See Profound Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 16.38M$ 10.68M$ 7.20M$ 6.68M$ 6.87M
Gross Profit
$ 11.59M$ 7.04M$ 4.38M$ 3.02M$ 2.95M
Operating Expenses
$ 53.57M$ 40.10M$ 33.00M$ 32.62M$ 33.24M
Depreciation and Amortization
$ 569.80K$ 936.00K$ 929.00K$ 1.60M$ 1.88M
EBITDA
$ -41.41M$ -32.13M$ -27.00M$ -26.60M$ -28.65M
Operating Income
$ -41.98M$ -33.06M$ -28.62M$ -32.13M$ -30.29M
Other Income/Expenses
$ -1.08M$ 5.24M$ 200.00K$ 3.74M$ -303.00K
Pretax Income
$ -43.06M$ -27.82M$ -28.45M$ -28.38M$ -30.59M
Net Income
$ -43.32M$ -27.82M$ -28.57M$ -28.67M$ -30.70M
Per Share Metrics
Basic EPS
$ -1.43$ -1.12$ -1.35$ -1.38$ -1.50
Diluted EPS
$ -1.43$ -1.12$ -1.35$ -1.38$ -1.50
Weighted Average Shares Outstanding
30.23M 24.77M 21.18M 20.77M 20.46M
Weighted Average Shares Outstanding (Diluted)
30.23M 24.77M 21.18M 20.77M 20.47M

Profound Medical Earnings and Revenue History